ArticleScience advances2026
Adipose-cartilage communication via EV-Mito-mtDNA signaling promotes osteoarthritis progression.
Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Obesity is a major risk factor for osteoarthritis (OA), yet the mechanisms linking excess adiposity to joint degeneration remain incompletely understood. Here, we identify adipocyte-derived extracellular vesicles enriched in mitochondrial components (EV-Mito) as pathogenic mediators that transfer mitochondrial DNA (mtDNA) to chondrocytes. The internalized mtDNA activates the cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) cytosolic DNA-sensing pathway, inducing inflammatory signaling, metabolic dysfunction, senescence, and cartilage degeneration in murine and human models. Genetic and pharmacological inhibition of cGAS-STING signaling attenuates cartilage damage, pain behaviors, and gait abnormalities. Population-level and interventional data further show that body fat percentage, rather than body mass index, is more closely associated with OA risk and severity. In an exercise cohort, high-intensity interval training selectively reduced adiposity and was associated with lower mtDNA abundance in synovial EV fractions enriched for adipose-associated EV markers, reduced synovial 2',3'-cyclic GMP-AMP levels, and superior improvement in OA symptoms. These findings define a conserved EV-Mito-mtDNA-cGAS-STING axis linking adipose tissue to joint pathology and highlight fat-targeted interventions as mechanistically informed strategies for preventing and treating obesity-associated OA.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.